Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Apr 25;27(4):326-337. doi: 10.3760/cma.j.cn441530-20240313-00096.
Chronic constipation is one of the common gastrointestinal disorders, with an incidence rate that is gradually increasing yearly and becoming an important chronic disease that affects people's health and quality of life. In recent years, significant progress has been made in the basic and clinical research of chronic constipation, especially the gut microbiota therapy methods have received increasing attention. Therefore, under the initiative of the Parenteral and Enteral Nutrition Branch of the Chinese Medical Association, Chinese Society for the Promotion of Human Health Science and Technology, and Committee on Gut Microecology and Fecal Microbiota Transplantation, experts from relevant fields in China have been organized to establish the "" committee. Focusing on the dysbiosis of gut microbiota, the indications for gut microbiota therapy, and the protocols for fecal microbiota transplantation, 16 consensus opinions were proposed based on the review of domestic and international literature and the clinical experience of experts, aiming to standardize the clinical application of gut microbiota in chronic constipation.
慢性便秘是常见的胃肠道疾病之一，其发病率逐年逐渐上升，已成为影响人们健康和生活质量的重要慢性病。近年来，慢性便秘的基础和临床研究取得了显著进展，尤其是肠道微生物群治疗方法受到越来越多的关注。因此，在中国医师协会肠外肠内营养学分会、中国健康促进与教育协会、肠道微生态与粪菌移植学组的倡议下，组织了国内相关领域专家成立了“……委员会”。围绕肠道微生物群失调、肠道微生物群治疗的适应证以及粪菌移植方案，在查阅国内外文献和专家临床经验的基础上提出了16条共识意见，旨在规范肠道微生物群在慢性便秘中的临床应用。
